PharmaShots

APRIL 25, 2023

In 2019, Mallinckrodt entered into a collaboration agreement with Silence Therapeutics to develop and commercialize RNAi therapeutics to treat life-threatening unmet diseases. Through the 2019 agreement, Mallinckrodt received the exclusive worldwide license to Silence’s SLN500. R&D Expenditure: $85.1M

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Diabetes Packaging Immunity 40

RX Note

FEBRUARY 23, 2023

Soft Contact Lenses - A basic overview Red Eye - Discussion on few possible conditions Styes - Warm compresses are the mainstay of treatment Eye Floaters - It is not often treated, except in severe cases.

HIV Treatment and Prevention Agents 75

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 75

The Thyroid Pharmacist

JULY 20, 2023

8] A more recent 2019 study looked at the levels of three important nutrients for thyroid health: iodine, iron, and selenium. [9] And as we’ve seen, even with supplementation, you need to address your root causes to prevent iron supply and demand challenges. Too much iron/ferritin can be a problem. However, when they added 1.5

Health and Personal Care Stores 92

Health and Personal Care Stores HIV Treatment and Prevention Agents Immunity Immunization 92

The Thyroid Pharmacist

JANUARY 20, 2023

Nikolai Lazarev defined adaptogens as “an agent that raises the body’s ability to resist stress by countering undesired stressors, whether physical, chemical, emotional, or biological.” The first case is outlined in a 2019 report by Roberto Vita and his research team, and published in Revista da Associação Médica Brasileira.

HIV Treatment and Prevention Agents 98

HIV Treatment and Prevention Agents Diabetes Immunity Immunization 98